Jeffrey C. Lombardo, PharmD, BCOP

home / authors / jeffrey-c-lombardo-pharmd-bcop

Articles

Challenges and Innovations in the Manufacture of Hazardous Drugs

Challenges and Innovations in the Manufacture of Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP
January 11th 2019

USP General Chapter , which was published by the United States Pharmacopeial Convention and updated most recently in December 2017, sets forth guidelines for the handling of hazardous drugs in the health care setting with the goal of promoting safety for patients and health care workers.

Read More

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP;Rachel L. Brown, PharmD, MPH
May 24th 2018

Read More

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Evaluating Effective Protective Measures for Minimizing the Risk of Exposure to Hazardous Drugs

Jeffrey C. Lombardo, PharmD, BCOP;Rachel L. Brown, PharmD, MPH
February 22nd 2018

Continuing education activity featured in the March 2018 edition of Pharmacy Times.

Read More

Latest Updated Articles

raw vegetables with blood glucose meter, syringe, lancet and stethoscope on desk, diabetes healthy diet concept - Image credit: neirfy | stock.adobe.com
Published: June 12th 2025 | Updated: June 16th 2025
Study: How Individual Carbohydrate Responses Reveal Metabolic Health and Potential Biomarkers
Milan, Italy - APRIL 10, 2021: CDC logo on laptop screen seen through an optical prism. Illustrative editorial image from CDC website.
Published: June 10th 2025 | Updated: June 12th 2025
Department of Health and Human Services Reconstitutes ACIP, Removing 17 Sitting Members
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Published: June 2nd 2025 | Updated: June 11th 2025
NLA 2025: Managing Omega-3 Therapy With Statins, PCSK9 Inhibitors for Cardiovascular Care
Image credit: catalin | stock.adobe.com
Published: June 3rd 2025 | Updated: June 11th 2025
ASCO 2025: Zongertinib Shows Strong Potential in HER2-Mutant NSCLC Treatment Landscape
Emerging Data: Impacts of ROCKstar and AGAVE-201
Published: May 30th 2025 | Updated: June 5th 2025
Emerging Data: Impacts of ROCKstar and AGAVE-201
Mother holding baby's foot with measles spots | Image Credit: © rostock-studio - stock.adobe.com
Published: April 18th 2025 | Updated: April 21st 2025
Measles Cases Climb to 800 in United States as Outbreak Spreads Across Borders
© 2025 MJH Life Sciences

All rights reserved.